Eligibility Criteria Studies were eligible if they evaluated BPC-157, thymosin beta-4 or marketed derivatives (including TB-500), GHK-Cu, or other peptide-based agents commonly promoted for musculoskeletal healing or recovery and reported outcomes relevant to musculoskeletal pathology, orthopaedic surgery, postoperative recovery, or perioperative risk domains
[DOI] [PMC free article] [PubMed] [Google Scholar] 70.Kuo YC, Chiu KH
Naturally, the complexity of a murine model might involve additional effects of glucocorticoids for which we cannot fully control
1 capsule provides 250mg S-acetyl L-glutathione
Hu H, Zhang W, Zhou Y, Zhao K, Kuang J, Liu X, Li G, Xi Y (2024) Engineered mitochondrial ROS scavenger nanocomplex to enhance lung biodistribution and reduce inflammation for the treatment of ARDS